{
    "Trade/Device Name(s)": [
        "BD Phoenix Automated Microbiology System Ampicillin-sulbactam (2/1-32/16 \u03bcg/mL)",
        "BD PhoenixM Automated Microbiology System for use with the antimicrobial agent ampicillin-sulbactam (2/1-32/16 \u03bcg/mL) - Gram positive ID/AST or AST only Phoenix Panels"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K050089",
    "Predicate Device Reference 510(k) Number(s)": [
        "N50510",
        "K020321",
        "K020323",
        "K020322"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "February 28, 2005",
    "Summary Letter Received Date": "January 14, 2005",
    "Submission Date": "January 12, 2005",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility Devices"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Ampicillin-sulbactam"
    ],
    "Specimen Type(s)": [
        "Pure culture isolates of Gram-positive bacteria",
        "Pure culture isolates of Gram-negative aerobic and facultative anaerobic bacteria"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD Phoenix Automated Microbiology System"
    ],
    "Method(s)/Technology(ies)": [
        "Broth-based microdilution",
        "Redox indicator detection",
        "Automated antimicrobial susceptibility testing"
    ],
    "Methodologies": [
        "Quantitative determination of antimicrobial susceptibility",
        "Minimal inhibitory concentration (MIC) determination"
    ],
    "Submission Type(s)": [
        "System",
        "Panel",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for BD Phoenix Automated Microbiology System with Ampicillin-sulbactam addition for automated antimicrobial susceptibility testing of Gram-positive and Gram-negative isolates.",
    "Indications for Use Summary": "For in vitro quantitative determination of antimicrobial susceptibility by minimal inhibitory concentration (MIC) of Gram-negative aerobic and facultative anaerobic bacteria and Gram-positive bacteria from pure cultures, including Enterobacteriaceae, Non-Enterobacteriaceae, Staphylococcus, and Enterococcus, using ampicillin-sulbactam (2/1-32/16 \u03bcg/mL) in Phoenix panels.",
    "fda_folder": "Microbiology"
}